Description
The authors hypothesize that age is decisive in neurodegenerative diseases while neuropathology is critical in neuroimmunological diseases for COVID-19 susceptibility, but the biological basis for this differential vulnerability remains unexplained. This could inform risk stratification and protective strategies.
Gap type: unexplained_observation Source paper: COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? (2021, Journal of neurology, PMID:32696341)